Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

201 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A comprehensive SARS-CoV-2-human protein-protein interactome reveals COVID-19 pathobiology and potential host therapeutic targets.
Zhou Y, Liu Y, Gupta S, Paramo MI, Hou Y, Mao C, Luo Y, Judd J, Wierbowski S, Bertolotti M, Nerkar M, Jehi L, Drayman N, Nicolaescu V, Gula H, Tay S, Randall G, Wang P, Lis JT, Feschotte C, Erzurum SC, Cheng F, Yu H. Zhou Y, et al. Among authors: jehi l. Nat Biotechnol. 2023 Jan;41(1):128-139. doi: 10.1038/s41587-022-01474-0. Epub 2022 Oct 10. Nat Biotechnol. 2023. PMID: 36217030 Free PMC article.
A Network Medicine Approach to Investigation and Population-based Validation of Disease Manifestations and Drug Repurposing for COVID-19.
Zhou Y, Hou Y, Shen J, Kallianpur A, Zein J, Culver DA, Farha S, Comhair S, Fiocchi C, Gack MU, Mehra R, Stappenbeck T, Chan T, Eng C, Jung JU, Jehi L, Erzurum S, Cheng F. Zhou Y, et al. Among authors: jehi l. ChemRxiv [Preprint]. 2020 Jul 2. doi: 10.26434/chemrxiv.12579137. ChemRxiv. 2020. Update in: PLoS Biol. 2020 Nov 6;18(11):e3000970. doi: 10.1371/journal.pbio.3000970. PMID: 32676577 Free PMC article. Updated. Preprint.
A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19.
Zhou Y, Hou Y, Shen J, Mehra R, Kallianpur A, Culver DA, Gack MU, Farha S, Zein J, Comhair S, Fiocchi C, Stappenbeck T, Chan T, Eng C, Jung JU, Jehi L, Erzurum S, Cheng F. Zhou Y, et al. Among authors: jehi l. PLoS Biol. 2020 Nov 6;18(11):e3000970. doi: 10.1371/journal.pbio.3000970. eCollection 2020 Nov. PLoS Biol. 2020. PMID: 33156843 Free PMC article.
Multimodal single-cell omics analysis identifies epithelium-immune cell interactions and immune vulnerability associated with sex differences in COVID-19.
Hou Y, Zhou Y, Gack MU, Lathia JD, Kallianpur A, Mehra R, Chan TA, Jung JU, Jehi L, Eng C, Cheng F. Hou Y, et al. Among authors: jehi l. Signal Transduct Target Ther. 2021 Jul 30;6(1):292. doi: 10.1038/s41392-021-00709-x. Signal Transduct Target Ther. 2021. PMID: 34330889 Free PMC article. Clinical Trial.
201 results